These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12085245

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo.
    Shaw JA, Delday MI, Hart AW, Docherty HM, Maltin CA, Docherty K.
    J Endocrinol; 2002 Mar; 172(3):653-72. PubMed ID: 11874714
    [Abstract] [Full Text] [Related]

  • 3. Glucose-regulated insulin production in hepatocytes.
    Alam T, Sollinger HW.
    Transplantation; 2002 Dec 27; 74(12):1781-7. PubMed ID: 12499898
    [Abstract] [Full Text] [Related]

  • 4. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
    Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, Karnieli E.
    Diabetologia; 2007 Jan 27; 50(1):121-30. PubMed ID: 17131142
    [Abstract] [Full Text] [Related]

  • 5. Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin.
    Falqui L, Martinenghi S, Severini GM, Corbella P, Taglietti MV, Arcelloni C, Sarugeri E, Monti LD, Paroni R, Dozio N, Pozza G, Bordignon C.
    Hum Gene Ther; 1999 Jul 20; 10(11):1753-62. PubMed ID: 10446915
    [Abstract] [Full Text] [Related]

  • 6. Tetracycline-regulated secretion of human (pro)insulin following plasmid-mediated transfection of human muscle.
    Wilson MO, Scougall KT, Ratanamart J, McIntyre EA, Shaw JA.
    J Mol Endocrinol; 2005 Apr 20; 34(2):391-403. PubMed ID: 15821105
    [Abstract] [Full Text] [Related]

  • 7. Enhanced expression of a furin-cleavable proinsulin.
    Hay CW, Docherty K.
    J Mol Endocrinol; 2003 Dec 20; 31(3):597-607. PubMed ID: 14664719
    [Abstract] [Full Text] [Related]

  • 8. Insulin delivery with plasmid DNA.
    Abai AM, Hobart PM, Barnhart KM.
    Hum Gene Ther; 1999 Nov 01; 10(16):2637-49. PubMed ID: 10566891
    [Abstract] [Full Text] [Related]

  • 9. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice.
    Short DK, Okada S, Yamauchi K, Pessin JE.
    Am J Physiol; 1998 Nov 01; 275(5):E748-56. PubMed ID: 9814992
    [Abstract] [Full Text] [Related]

  • 10. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I.
    Giannoukakis N, Mi Z, Rudert WA, Gambotto A, Trucco M, Robbins P.
    Gene Ther; 2000 Dec 01; 7(23):2015-22. PubMed ID: 11175313
    [Abstract] [Full Text] [Related]

  • 11. Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA.
    Yamasaki K, Sasaki T, Nemoto M, Eto Y, Tajima N.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):361-5. PubMed ID: 10558872
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
    Croze F, Prud'homme GJ.
    J Gene Med; 2003 May 19; 5(5):425-37. PubMed ID: 12731091
    [Abstract] [Full Text] [Related]

  • 13. Engineering physiologically regulated insulin secretion in non-beta cells by expressing glucagon-like peptide 1 receptor.
    Wu L, Nicholson W, Wu CY, Xu M, McGaha A, Shiota M, Powers AC.
    Gene Ther; 2003 Sep 19; 10(19):1712-20. PubMed ID: 12923570
    [Abstract] [Full Text] [Related]

  • 14. Human liver-derived cells stably modified for regulated proinsulin secretion function as bioimplants in vivo.
    Chen X, Patil JG, Lok SH, Kon OL.
    J Gene Med; 2002 Sep 19; 4(4):447-58. PubMed ID: 12124987
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures.
    Simonson GD, Groskreutz DJ, Gorman CM, MacDonald MJ.
    Hum Gene Ther; 1996 Jan 19; 7(1):71-8. PubMed ID: 8825870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Partial pancreatic transdifferentiation of primary human hepatocytes in the livers of a humanised mouse model.
    Ren B, La QT, O'Brien BA, Nassif NT, Tan Y, Gerace D, Martiniello-Wilks R, Torpy F, Dane AP, Alexander IE, Simpson AM.
    J Gene Med; 2018 May 19; 20(5):e3017. PubMed ID: 29578255
    [Abstract] [Full Text] [Related]

  • 20. Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes.
    Gan SU, Fu Z, Sia KC, Kon OL, Calne R, Lee KO.
    J Gene Med; 2019 Jan 19; 21(1):e3067. PubMed ID: 30592790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.